Bayer | BAYN - Cost Of Sales

Stock Price
40.45
Daily Change
-0.03 -0.07%
Monthly
2.08%
Yearly
103.35%
Q2 Forecast
38.53

Bayer reported EUR4.5B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Air Liquide EUR 5.9B 415.5M Dec/2025
Akzo Nobel EUR 1.44B 84M Dec/2025
Alcon AG USD 1.2B 46M Dec/2025
Amarin USD 26.05M 1.41M Dec/2025
Arkema EUR 1.79B 12M Dec/2025
AstraZeneca USD 3.27B 471M Dec/2025
BASF EUR 10.93B 241M Dec/2025
Bayer EUR 4.5B 194M Dec/2025
Beiersdorf EUR 2.06B 50M Dec/2025
Corteva USD 2.41B 607M Dec/2025
Covestro EUR 2.7B 5.39B Dec/2025
Essilor EUR 6.06B 741M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Genmab DKK 81M 23M Dec/2025
Givaudan CHF 2.07B 105M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.29B 163.12M Dec/2025
Henkel EUR 4.96B 110M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Johnson Matthey GBP 5.04B 513M Dec/2025
Linde USD 5.5B 1.12B Dec/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.29B 183M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Nutrien USD 3.45B 591M Dec/2025
Philips EUR 2.81B 417M Dec/2025
PPG Industries USD 2.45B 24M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
SAP EUR 2.56B 1.49B Dec/2025
Solvay EUR 860M 71M Dec/2025
UCB EUR 1.07B 146M Dec/2025
Umicore EUR 8.22B 4.83B Jun/2025
Vinci EUR 9.07B 632M Jun/2025